Back
Canopy Growth Vs. Grace Therapeutics Industry Stock Comparison
Buy
54
CGC
Canopy Growth
Last Price:
5.49
Seasonality Move:
34.7%
Sell
39
GRCE
Grace Therapeutics
Last Price:
3.08
Seasonality Move:
7.4%
Buy
54
Canopy Growth (CGC)
is a Buy
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [CGC] share price is $4.86. The Score for CGC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CGC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Grace Therapeutics (GRCE)
is a Sell
Is Grace Therapeutics a Buy, Sell or Hold?
- The current Grace Therapeutics [GRCE] share price is $3.10. The Score for GRCE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- GRCE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CGC Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $4.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CGC is experiencing slight buying pressure.
GRCE Stock Price Chart
What is Grace Therapeutics's stock price today?
-
The Grace Therapeutics share price today is $3.10
The current trend is moderately bearish and GRCE is experiencing slight buying pressure.
CGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 51.85 | Buy |
| Chaikin Money Flow: | 2057478 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.14 - 5) | Buy |
| Bollinger Bands (100): | (4.67 - 7.01) | Sell |
GRCE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 47.99 | Sell |
| Chaikin Money Flow: | 5006 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.08 - 3.38) | Sell |
| Bollinger Bands (100): | (2.53 - 3.21) | Buy |
CGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.06 | Sell |
| 20-day SMA: | 4.58 | Buy |
| 50-day SMA: | 4.78 | Buy |
| 200-day SMA: | 6.23 | Sell |
| 8-day EMA: | 4.9 | Sell |
| 20-day EMA: | 4.77 | Buy |
| 50-day EMA: | 5.02 | Sell |
| 200-day EMA: | 6.62 | Sell |
GRCE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.27 | Sell |
| 20-day SMA: | 3.27 | Sell |
| 50-day SMA: | 2.9 | Buy |
| 200-day SMA: | 2.93 | Buy |
| 8-day EMA: | 3.2 | Sell |
| 20-day EMA: | 3.2 | Sell |
| 50-day EMA: | 3.02 | Buy |
| 200-day EMA: | 2.89 | Buy |
Canopy Growth Earnings Growth & CGC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.78 per share, and an increase next year of $0.52 per share.
Grace Therapeutics Earnings Growth & GRCE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and a decrease next year of $0.01 per share.
Canopy Growth Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Grace Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||